henhaobio
Sign in

Antimicrobial Agents and ChemotherapyMicrobiologyPeer-reviewed journal article

Disparate effects of metformin on Mycobacterium tuberculosis infection in diabetic and non-diabetic mice

H. Sathkumara, K. Hansen, S. Miranda-Hernandez, B. Govan, C. Rush, L. Henning, N. Ketheesan, A. Kupz

PDFDOIPreprint

Abstract

Comorbid type 2 diabetes poses a great challenge to the global control of tuberculosis. Here we assessed the efficacy of metformin (MET); an anti-diabetic drug, in mice infected with a very-low dose of Mycobacterium tuberculosis. In contrast to diabetic mice, infected non-diabetic mice that received the same therapeutic concentration of MET presented with significantly higher disease burden. This warrants further studies to investigate the disparate efficacy of MET against tuberculosis in diabetic and non-diabetic individuals.

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.